ARTICLES BY BIOPHORUM
-
![successful choice vector, different way, opposite direction traffic sign-GettyImages-2197175690]( "Improving Execution Of Biological Evaluation Of Drug Delivery Devices")
Improving Execution Of Biological Evaluation Of Drug Delivery Devices6/3/2026This article provides a framework to streamline the biological safety assessment process, reduce testing burdens, and improve patient safety for combination products.
-
![Checklist-GettyImages-695733892]( "Rethinking CQV In A Digital, Agile Manufacturing Landscape")
Rethinking CQV In A Digital, Agile Manufacturing Landscape5/21/2026While commissioning, qualification, and validation (CQV) remains foundational, the way it is planned and executed must evolve to keep pace with modern manufacturing realities.
-
![Reunification and accession-GettyImages-2168520923]( "Closing The MES Value Gap: Why Technology Isn't The Problem")
Closing The MES Value Gap: Why Technology Isn't The Problem5/14/2026Manufacturing execution system (MES) technical maturity is rising, but adoption across manufacturing sites is uneven. Organizational readiness may hold the key.
-
![Mistakes To Avoid-GettyImages-1985714645]( "Why Your MES RFP Is Failing Before It Starts")
Why Your MES RFP Is Failing Before It Starts5/6/2026Many manufacturing execution system requests for proposals fail. Not because vendors cannot deliver or the tech is immature, but because the requirements are written backward.
-
![Old ways won't open new dorrs-GettyImages-696063644]( "MES Is Still In The CD ROM Era But The Data Architecture Has Moved On")
MES Is Still In The CD ROM Era But The Data Architecture Has Moved On2/20/2026Many manufacturing execution system (MES) deployments still operate like it is 2005: a big install, disruptive upgrades, etc. Here's a clearer path forward.
-
![teamwork, celebration, success, achievement-GettyImages-2215022093]( "Improving Drug-Device Combination Product Co-Development")
Improving Drug-Device Combination Product Co-Development8/8/2025Early recognition and mitigation of drug and device integration difficulties are critical to the success of combination products. The collaborative effort in development cannot be overstated.
